Improving lithium carbonate therapeutics by pegylated liposomal technology: an in vivo study

详细信息    查看全文

• 作者：Yasaman Hosseini ; Seyed Ebrahim Alavi ; Azim Akbarzadeh…
• 关键词：Bipolar disorder ; Liposome ; Lithium carbonate ; Nanotechnology ; Polyethylene glycol
• 刊名：Comparative Clinical Pathology
• 出版年：2016
• 出版时间：January 2016
• 年：2016
• 卷：25
• 期：1
• 页码：211-218
• 全文大小：457 KB
• 参考文献：Amarnath S, Sharma US (1997) Liposomes in drug delivery: progress and limitations. Int J Pharm 154:123–140CrossRef
  Ani M, Moshtaghie AA, Akbarzadeh S (2005) Changes in biochemical parameters related to lipid metabolism following lithium treatment in rat. Iran Biomed J 9:27–32
  Cervantes F, Mesa R, Barosi G (2007) New and old treatment modalities in primary myelofibrosis. Cancer J 13:377–383PubMed CrossRef
  Chen CH, Suckling J, Lennox BR, Ooi C, Bullmore ET (2011) A quantitative meta-analysis of fMRI studies in bipolar disorder. Bipolar Disord 13:1–15PubMed CrossRef
  Cheng HC, Chang CY, Hsieh FI, Yeh JJ, Chien MY, Pan RN, Deng MC, Liu DZ (2011) Effects of tremella-alginate-liposome encapsulation on oral delivery of inactivated H5N3 vaccine. J Microencapsul 28:55–61PubMed CrossRef
  Cheong I, Zhou S (2009) Tumor-specific liposomal drug release mediated by liposomase. Methods Enzymol 465:251–265PubMed CrossRef
  Christian GD (2002) Reagents for lithium electrodes and sensors for blood serum analysis. Sensors 2:432–435CrossRef
  Chudal R, Sucksdorff D, Suominen A, Lehti V, Hinkka-Yli-Salomäki S, Huttunen J, Ristkari T, Gissler M, McKeague IW, Brown AS, Sourander A (2014) Finnish prenatal study of bipolar disorders (FIPS-B): overview, design and description of the sample. Nord J Psychiatry 68:169–179PubMed CrossRef
  Clough Z, Henry R, Ekelund A (2014) Delirium associated with therapeutic levels of lithium in bipolar disorder. Prog Neurol Psychiatry 18:10–12CrossRef
  Costantino L, Boraschi D (2012) Is there a clinical future for polymeric nanoparticles as brain-targeting drug delivery agents? Drug Discov Today 17:367–378PubMed CrossRef
  Dikpati A, Madgulkar AR, Kshirsagar SJ, Bhalekar MR, Singh Chahal A (2012) Targeted drug delivery to CNS using nanoparticles. J Adv Pharm Sci 2:79–191
  Espirito Santo CE, Carvalho TMJP (2014) Determination of serum lithium: comparison between atomic emission and absorption spectrometry methods. J Bras Patol Med Lab 49:12CrossRef
  Fountoulakis KN, Kelsoe JR, Akiskal H (2012) Receptor targets for antidepressant therapy in bipolar disorder: an overview. J Affect Disord 138:222–238PubMed CrossRef
  Fukumoto T, Morinobu S, Okamoto Y, Kagaya A, Yamawaki S (2001) Chronic lithium treatment increases the expression of brain-derived neurotrophic factor in the rat brain. Psychopharmacology (Berlin) 158:100–106CrossRef
  Geddes JR, Miklowitz DJ (2013) Treatment of bipolar disorder. Lancet 381:1672–1682PubMed CrossRef
  Goodwin GM, Consensus Group of the British Association for Psychopharmacology (2009) Evidence-based guidelines for treating bipolar disorder: revised second edition--recommendations from the British Association for Psychopharmacology. J Psychopharmacol 23:346–388PubMed CrossRef
  Handa T, Naito S, Hiramatsu M, Tsuboi M (2006) Thermal SiO and H13CO+ line observations of the dense molecular cloud G0.11-0.11 in the galactic center region. Astrophys J 636:261–266CrossRef
  Himanshu A, Sitasharan P, Singhai AK (2011) Liposomes as drug carriers. IJPLS 2:945–951
  Irache JM, Esparza I, Gamazo C, Agüeros M, Espuelas S (2011) Nanomedicine: novel approaches in human and veterinary therapeutics. Vet Parasitol 180:47–71PubMed CrossRef
  Italia JL, Bhatt DK, Bhardwaj V, Tikoo K, Kumar MN (2007) PLGA nanoparticles for oral delivery of cyclosporine: nephrotoxicity and pharmacokinetic studies in comparison to Sandimmune Neoral. J Control Release 119:197–206PubMed CrossRef
  Iwanaga K, Ono S, Narioka K, Kakemi M, Morimoto K, Yamashita S, Namba Y, Oku N (1999) Application of surface-coated liposomes for oral delivery of peptide: effects of coating the liposome’ssurface on the GI transit of insulin. J Pharm Sci 88:248–252PubMed CrossRef
  Jurgons R, Seliger C, Hilpert A, Trahms L, Odenbach S, Alexiou C (2006) Drug loaded magnetic nanoparticles for cancer therapy. J Phys Condens Matter 18:S2893–S2902CrossRef
  Kawai F (2002) Microbial degradation of polyethers. Appl Microbiol Biotechnol 58:30–38PubMed CrossRef
  Lasic DD (1998) Novel applications of liposomes. Trends Biotechnol 16:307–321PubMed CrossRef
  Leyhe T, Eschweiler GW, Stransky E, Gasser T, Annas P, Basun H, Laske C (2009) Increase of BDNF serum concentration in lithium treated patients with early Alzheimer’s disease. J Alzheimers Dis 16:649–656PubMed
  Lian T, Ho RJ (2001) Trends and developments in liposome drug delivery systems. J Pharm Sci 90:667–680PubMed CrossRef
  Madetoja J, Madetoja M, Mäkinen J, Riuttala E, Jokinen J (2009) Blood sampling from the tail vein, in comparison with two other techniques, causes less stress to mice. Scand J Lab Anim Sci 36:215–221
  Masserini M (2013) Nanoparticles for brain drug delivery. ISRN Biochem 2013:18CrossRef
  Michelon L, Vallada H (2005) Fatores genéticos e ambientais na manifestação do transtorno bipolar. Rev Psiq Clin 32:21–27CrossRef
  Mu L, Feng SS (2003) PLGA/TPGS nanoparticles for controlled release of paclitaxel: effects of the emulsifier and drug loading ratio. Pharm Res 20:1864–1872PubMed CrossRef
  Nakase I, Lai H, Singh NP, Sasaki T (2008) Anticancer properties of artemisinin derivatives and their targeted delivery by transferrin conjugation. Int J Pharm 354:28–33PubMed CrossRef
  Ning Z, Cheung CS, Fu J, Liu MA, Schnell MA (2006) Experimental study of environmental tobacco smoke particles under actual indoor environment. Sci Total Environ 367:822–830PubMed CrossRef
  Ochekpe NA, Olorunfemi PO, Ngwuluka NC (2009) Nanotechnology and drug delivery. Part 1: background and applications. Trop J Pharm Res 8:265–274
  Olya S, Khorvash M, Rahmani HR, Esmaeilkhanian S, Olya B, Sadri H (2014) Oral delivery of insulin-loaded nanoparticles in diabetic rabbits and in sheep. Czech J Anim Sci 59:251–256
  Otsuka H, Nagasaki Y, Kataoka K (2012) PEGylated nanoparticles for biological and pharmaceutical applications. Adv Drug Deliv Rev 64:246–255CrossRef
  Sadock BJ, Sadock VA, Ruiz P (2009) Kaplan and Sadock’s comprehensive textbook of psychiatry (2 volume set). Lippincott Williams & Wilkins (LWW), Philadelphia
  Shallie PD, Adefule AK, Akpan HB, Fakoya D, Adejumo EN (2010) Analysis of some lipid parameters following lithium administration. Afr J Pharm Pharacol 4:202–206
  Smith AJ, Kim SH, Duggirala NK, Jin J, Wojtas L, Ehrhart J, Giunta B, Tan J, Zaworotko MJ, Shytle RD (2013) Improving lithium therapeutics by crystal engineering of novel ionic cocrystals. Mol Pharm 10:4728–4738PubMed PubMedCentral CrossRef
  William ZP, Leo EH (2006) Antipsychotic agents & lithium. In: Bertram G (ed) Basic and clinical pharmacology America: K LANGE medical book. McGraw-Hill Companies, Columbus, pp 490–495
  Yang T, Choi MK, Cui FD, Kim JS, Chung SJ, Shim CK, Kim DD (2007) Preparation and evaluation of paclitaxel-loaded PEGylated immunoliposome. J Control Release 120:169–177PubMed CrossRef
  
• 作者单位：Yasaman Hosseini (1)
  Seyed Ebrahim Alavi (1) (2)
  Azim Akbarzadeh (2)
  Amir Heidarinasab (1)
  
  1. Department of Chemical Engineering, Science and Research Branch, Islamic Azad University, Tehran, Iran
  2. Department of Pilot Nanobiotechnology, Pasteur Institute of Iran, Tehran, Iran
  
• 刊物类别：Medicine
• 刊物主题：Medicine & Public Health
  Pathology
  Hematology
  Oncology
  
• 出版者：Springer London
• ISSN：1618-565X

文摘

Bipolar disorder is a chronic mental illness which is associated with high risk of self-harm and suicide. Lithium carbonate has been suggested as a medicine to control and cure this disease. To overcome the complications related to taking lithium carbonate, nanotechnology has come to the aid of scientists. In this study, pegylated liposomal lithium carbonate nanoparticles were prepared by the reverse phase evaporation method to improve the drug’s therapeutic characteristics as well as lessening its side effects. In order to synthesize pegylated liposomal lithium carbonate, phosphatidylcholine, polyethylene glycol 3350 (PEG3350), cholesterol, and lithium carbonate were mixed. The characterization of synthesized nanoparticles was determined by Zetasizer. Encapsulation and drug loading efficiency and release pattern studies were determined through spectrophotometry method. In addition, serum lithium and creatinine levels of the samples were analyzed. The mean diameter, size distribution, and zeta potential for pegylated liposomal particles containing lithium carbonate and blank pegylated liposomal were determined by Zetasizer equal to 102 nm, 0.458, and −25.1 mV; 284.2 nm, 0.427, and −28.3 mV, respectively. Drug loading and encapsulation efficiency were calculated to be 32.87 and 97.4 %, respectively. The drug release pattern demonstrated that the half-life of the nanodrug was approximately two times higher than the standard drug. The results related to the analysis of serum lithium and creatinine levels indicated that the efficiency of liposomal drug formulation was increased compared to the standard drug. Based on the findings, the nanodrug enjoyed a half-life two times higher than that of the standard drug and an efficiency level equal to it. Keywords Bipolar disorder Liposome Lithium carbonate Nanotechnology Polyethylene glycol